• -
  • English
  • Japanese
  • Korean
市場調查報告書
商品編碼
950965

持續血糖監測系統 (CGM)的全球市場:各零件、各年齡結構、各終端用戶、各地區 - 市場分析，規模，佔有率，趨勢，預測 (2020∼2026年)

Continuous Glucose Monitoring Market, By Component, By Demographic, By End User, and By Geography - Analysis, Size, Share, Trends, & Forecast from 2020-2026
出版日期: | 出版商: AnalystView Market Insights | 英文 218 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球持續血糖監測系統 (CGM)的市場規模，預計2019年達到38億7000萬美元，2020∼2026年間更將以11.9％的年複合成長率成長。糖尿病患者的增加和微創治療設備的人氣擴大等，成為市場成長的大要素。各零件中，感測器佔著市場大半。

本報告提供全球持續血糖監測系統 (CGM)的市場調查分析，市場定義和基本結構，主要的推動及阻礙市場要素，產業的競爭力、向心力，市場佔有率結構，各零件、各年齡結構、各終端用戶、各地區的市場趨勢預測 (過去5年、今後7年份)，主要企業的簡介等相關調查。

第1章 持續血糖監測系統 (CGM) 市場概要

第2章 摘要整理

第3章 持續血糖監測系統 (CGM):主要的市場趨勢

  • 推動市場要素
    • 推動市場要素的影響度分析
  • 阻礙市場要素
    • 阻礙市場要素的影響度分析
  • 市場機會
  • 未來市場趨勢

第4章 持續血糖監測系統 (CGM):產業研究

  • 波特的五力分析
  • 行銷策略分析
  • 市場成長預測:製圖
  • 管理體制分析
  • 新型冠狀病毒感染疾病 (Covid-19)的影響分析
    • Covid-19以前的影響分析
    • 的影響分析Covid-19以後

第5章 持續血糖監測系統 (CGM):市場環境

  • 市場佔有率分析
  • 主要的技術創新企業 (創新者)
  • 市場區隔資料:各主要製造商
    • 現有企業分析
    • 新企業分析

第6章 持續血糖監測系統 (CGM) 市場:各零件

  • 概要
  • 耐用品 (接收機、發送器)
  • 感測器
  • 胰島素幫浦

第7章 持續血糖監測系統 (CGM) 市場:各年齡結構

  • 概要
  • 兒童用
  • 成人用

第8章 持續血糖監測系統 (CGM) 市場:各終端用戶

  • 概要
  • 醫院
  • 加護病房 (ICU)
  • 家庭診斷
  • 其他

第9章 持續血糖監測系統 (CGM) 市場:各地區

  • 簡介
    • 市場佔有率分析:各地區 (2019年，2026年)
  • 北美市場
    • 概要
    • 域內的主要製造商
    • 市場規模與其預測:各國 (以金額為準，2015∼2026年)
    • 市場規模與其預測:各零件 (以金額為準，2015∼2026年)
    • 市場規模與其預測:各年齡結構 (以金額為準，2015∼2026年)
    • 市場規模與其預測:各終端用戶 (以金額為準，2015∼2026年)
    • 美國
    • 加拿大
  • 歐洲市場
    • 德國
    • 義大利
    • 英國
    • 法國
    • 其他歐洲各國
  • 亞太地區 (APAC) 市場
    • 印度
    • 中國
    • 日本
    • 韓國
    • 其他的亞太地區各國
  • 南美市場
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他的南美各國
  • 中東、非洲市場
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國 (UAE)

第10章 供應商分析

  • Medtronic Plc.
  • Dexcom Inc.
  • Johnson & Johnson
  • Menarini Diagnostics
  • Abbott Diabetic Care
  • Animas Corporation
  • Echo Therapeutics
  • Insulet Corporation
  • Glysens Inc.
  • Senseonics, Inc.

第11章 分析師全方位展望

第12章 附錄

目錄

Title:
Continuous Glucose Monitoring Market, By Component (Durables, Sensors, and Insulin Pumps), By Demographic (Child Population and Adult Population), By End User (Hospitals, ICUs, Homecare Diagnostics), and By Geography (NA, APAC, LATAM, EU, and MEA) - Analysis, Size, Share, Trends, & Forecast from 2020-2026.

REPORT HIGHLIGHT

The continuous glucose monitoring market was valued at USD 3.87 billion by 2019, growing with 11.9% CAGR during the forecast period, 2020-2026.

Continuous glucose monitoring or CGM is one of the latest advancements in the diabetes management field. This product functions by putting or inserting a biosensor through a subcutaneous or transcutaneous route. The glucose levels are measured by the embedded sensor in blood or interstitial fluid and transmit the information by using a transmitter to a monitor/receiver for displaying the results. These CGM systems play an integral role in the field of diabetes management, due to the several advantages associated with them over other glucose monitoring devices.

MARKET DYNAMICS

The growing cases of diabetes and the increasing geriatric population all across the globe are the major factors boosting the growth of the global continuous glucose monitoring (CGM) market. According to the International Diabetes Federation (IDF), around 463 million adult populations aged 20 years and above all over the world we're living with diabetes. IDF estimates that this number is going to increase to 700 million by the end of 2045. Smoking, high blood pressure, physical inactivity, high cholesterol, and obesity are the common risk factors related to diabetes complications. Thus, the growing adoption of CGM devices and rising demand for minimally invasive treatment are projected to fuel the market growth.

Furthermore, the various advantages provided by CGM devices and the novel and innovative product developments by key industry players will provide lucrative growth opportunities for the overall market during the forecast period. For instance, in September 2019, Medtronic plc launched Envision Pro CGM System in Europe. The Envision Pro is a zero calibration, fully disposable professional CGM system that has received a CE (Conformite Europeenne) mark approval. The new technology will empower patients and their healthcare professionals with either type 1 or 2 diabetes to see precise glucose levels and trends in order to develop more optimal plans for diabetes therapy. However, inadequate reimbursement for CGM devices is expected to hamper the market growth in the coming future. On the contrary, enormous growth opportunities, especially in the untapped markets are predicted opportunities for the manufacturers to expand their business in the worldwide market in the near future.

COMPONENT TAKEAWAY

"Sensors segment to dominate the industry during the forecast period"

Based on the component, the global CGM market is trifurcated into durables, sensors, and insulin pumps. Among these, the sensors accounted for the majority of share in 2019 and are expected to dominate the market during the forecast period. Sensors are the most important part of the CGM device. These sensors detect blood sugar levels by using glucose oxidase. The dominance of this segment is majorly attributed to recurring sales of CGM sensors, bulk purchases, and short scrap life. Thus, these sensors are deployed in clinics and diagnostic centers. In addition, the growing adoption of CGM sensors in-home healthcare and hospital ICUs healthcare settings has surged in recent years.

Demographic Takeaway

"Adult population segment to witness the highest growth by 2026"

On the basis of demographics, the overall CGM market is bifurcated into the child and adult population. Of these, the adult segment is estimated to witness the highest growth in the forecast period. This is majorly owing to the fact that CGM is considered as a perfect tool for controlling diabetes in the adult population. Continuous glucose monitoring is a "ready-to-go" treatment, affordable for the working employed/class individuals, and efficient for diabetes management. Thus, CGMs are widely used for treating the adult population.

End-User Takeaway

"Homecare diagnostics segment to hold a significant market share in the projected timeframe"

Based on end-user, the worldwide market is classified into hospitals, ICUs, and homecare diagnostics. The homecare diagnostics segment registered for the largest market share in 2019 and is expected to grow at the highest CAGR during the period of forecast. This is mainly because patients find it convenient and it is also cost-efficient. In addition, the shift of healthcare emphasis towards the prevention of diseases and early detection is propelling the segmental market growth.

On the other hand, the hospital segment is anticipated to grow significantly during the projected period owing to the rising cases of diabetes across the globe and an increase in the number of visits to the hospitals. Moreover, the U.S. Food and Drug Administration (FDA) has approved the continuous glucose monitoring devices in the hospitals. For instance, in April 2019, Abbott has planned to donate 25,000 FreeStyle Libre CGM sensors to the hospitals during the COVID-19 pandemic. The company has partnered with Diabetes Response Coalition, Insulin for Life USA, and the American Diabetes Association (ADA) for this donation.

REGIONAL TAKEAWA

"North America region to be most lucrative by 2026"

Regionally, the global industry is divided into Europe, North America, Middle East & Africa, Asia Pacific, and Latin America. The North American market for continuous glucose monitoring is projected to lead the market during the estimated timeframe owing to high medical spending and the rising cases of diabetes in the region. According to the American Diabetes Association, around 34.2 million cases of diabetes were reported in 2018 in the U.S. of which around 1.6 million had Type 1 diabetes. In addition, the large presence of key players in the region is projected to drive regional market growth.

On the other hand, the Asia Pacific region is projected to grow at the highest CAGR in the forecast period. The presence of the large pool of diabetes patient population coupled with the rising demand for CGM devices is boosting the regional market growth. According to the International Diabetes Federation (IDF), around 88 million adults with diabetes were living in the South-East Asia (SEA) region in 2019. This number is further estimated to increase to 153 million by the end of 2045.

COVID-19 IMPACT

The continuous glucose monitoring (CGM) market is witnessing a progressive growth due to the outbreak of life-threatening COVID-19 virus all over the world. This is mainly because people with diabetes are at increased risk of catching COVID-19 disease. Thus, the CGM devices are being increasingly used by patients and care providers and patients to regularly check the blood glucose levels. Moreover, the FDA has issued guidance to expand the capability and availability of non-invasive monitoring devices such as the CGM during the COVID-19 pandemic. Conversely, the growth of the overall market is not as significant as expected due to the supply and demand gaps.

KEY VENDOR TAKEAWA

The leading players operating in the global continuous glucose monitoring industry include Medtronic Plc., Dexcom Inc., Johnson & Johnson, Menarini Diagnostics, Abbott Diabetic Care, Animas Corporation, Echo Therapeutics, Insulet Corporation, Glysens Inc., and Senseonics, Inc. These players are adopting several strategies such as mergers & acquisitions, collaborations, and geographical expansions to hold a strong position in the global market.

For instance, in May 2019, LifeScan and Sanvita Medical, LLC, entered into an agreement to market CGM (Continuous Glucose Monitoring) sensors. LifeScan is the maker of the OneTouch brand and is a global leader in blood glucose monitoring. The companies through this collaboration have planned to launch CGM systems in the North America region and selected countries in Europe. The novel CGM products will incorporate with LifeScan's digital portfolio, OneTouch Reveal® as well as the OneTouch Reveal application.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2015 to2018

Base Year - 2019

Estimated Year - 2020

Projected Year - 2026

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Government and Regional Agencies

Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET KEY PLAYERS

Abbott Diabetic Care

Animas Corporation

Echo Therapeutics

Medtronic Plc.

Dexcom Inc.

Johnson & Johnson

Menarini Diagnostics

Insulet Corporation

Glysens Inc.

Senseonics, Inc.

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY COMPONENT

Durables (Receivers and Transmitter)

Sensors

Insulin Pumps

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY DEMOGRAPHIC

Child Population

Adult Population

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY END USER

Hospitals

ICUs

Homecare Diagnostics

Others

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. CONTINUOUS GLUCOSE MONITORING MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Component
    • 2.1.2. Market Snippet by Demographic
    • 2.1.3. Market Snippet by End User
    • 2.1.4. Market Snippet by Region
  • 2.2. Competitive Insights

3. CONTINUOUS GLUCOSE MONITORING KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. CONTINUOUS GLUCOSE MONITORING INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis
  • 4.5. COVID-19 Impact Analysis
    • 4.5.1. Pre-COVID-19 Impact Analysis
    • 4.5.2. Post-COVID-19 Impact Analysis

5. CONTINUOUS GLUCOSE MONITORING MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. CONTINUOUS GLUCOSE MONITORING MARKET - BY COMPONENT

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Component, 2019 & 2026 (%)
  • 6.2. Durables (Receivers and Transmitter)
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.3. Sensors
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.4. Insulin Pumps
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. CONTINUOUS GLUCOSE MONITORING MARKET - BY DEMOGRAPHIC

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2019 & 2026 (%)
  • 7.2. Child Population
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.3. Adult Population
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. CONTINUOUS GLUCOSE MONITORING MARKET - BY END USER

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End User, 2019 & 2026 (%)
  • 8.2. Hospitals
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.3. ICUs
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.4. Homecare Diagnostics
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.5. Others
    • 8.5.1. Overview
    • 8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9. CONTINUOUS GLUCOSE MONITORING MARKET- BY GEOGRAPHY

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Component, 2015 - 2026 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Demographic, 2015 - 2026 (US$ Million)
    • 9.2.6. North America Market Size and Forecast, By End User, 2015 - 2026 (US$ Million)
    • 9.2.7. U.S.
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.2.8. Canada
      • 9.2.8.1. Overview
      • 9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Component, 2015 - 2026 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Demographic, 2015 - 2026 (US$ Million)
    • 9.3.6. Europe Market Size and Forecast, By End User, 2015 - 2026 (US$ Million)
    • 9.3.7. Germany
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.9. United Kingdom
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.10. France
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.11. Rest of Europe
      • 9.3.11.1. Overview
      • 9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Component, 2015 - 2026 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Demographic, 2015 - 2026 (US$ Million)
    • 9.4.6. Asia Pacific Market Size and Forecast, By End User, 2015 - 2026 (US$ Million)
    • 9.4.7. India
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.8. China
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.10. South Korea
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.11. Rest of APAC
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Component, 2015 - 2026 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Demographic, 2015 - 2026 (US$ Million)
    • 9.5.6. Latin America Market Size and Forecast, By End User, 2015 - 2026 (US$ Million)
    • 9.5.7. Brazil
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.8. Mexico
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.9. Argentina
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Component, 2015 - 2026 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Demographic, 2015 - 2026 (US$ Million)
    • 9.6.6. Middle East and Africa Market Size and Forecast, By End User, 2015 - 2026 (US$ Million)
    • 9.6.7. Saudi Arabia
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.6.8. United Arab Emirates
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

10. KEY VENDOR ANALYSIS

  • 10.1. Medtronic Plc.
    • 10.1.1. Company Snapshot
    • 10.1.2. Financial Performance
    • 10.1.3. Component Benchmarking
    • 10.1.4. Strategic Initiatives
  • 10.2. Dexcom Inc.
  • 10.3. Johnson & Johnson
  • 10.4. Menarini Diagnostics
  • 10.5. Abbott Diabetic Care
  • 10.6. Animas Corporation
  • 10.7. Echo Therapeutics
  • 10.8. Insulet Corporation
  • 10.9. Glysens Inc.
  • 10.10. Senseonics, Inc.

11. 360 DEGREE ANALYSTVIEW

12. APPENDIX

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Continuous Glucose Monitoring market: Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Component
  • TABLE Global Continuous Glucose Monitoring market, by Component 2015-2026 (USD Million)
  • TABLE Continuous Glucose Monitoring market: Demographic Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Demographic
  • TABLE Global Continuous Glucose Monitoring market, by Demographic 2015-2026 (USD Million)
  • TABLE Continuous Glucose Monitoring market: End UserSnapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Continuous Glucose Monitoring market, by End User2015-2026 (USD Million)
  • TABLE Continuous Glucose Monitoring market: RegionalSnapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Continuous Glucose Monitoring market, by Region 2015-2026 (USD Million)
  • TABLE North America Continuous Glucose Monitoring market, by Country, 2015-2026 (USD Million)
  • TABLE North America Continuous Glucose Monitoring market, by Component, 2015-2026 (USD Million)
  • TABLE North America Continuous Glucose Monitoring market, by Demographic, 2015-2026 (USD Million)
  • TABLE North America Continuous Glucose Monitoring market, by End User, 2015-2026 (USD Million)
  • TABLE Europe Continuous Glucose Monitoring market, by Country, 2015-2026 (USD Million)
  • TABLE Europe Continuous Glucose Monitoring market, by Component, 2015-2026 (USD Million)
  • TABLE Europe Continuous Glucose Monitoring market, by Demographic, 2015-2026 (USD Million)
  • TABLE Europe Continuous Glucose Monitoring market, by End User, 2015-2026 (USD Million)
  • TABLE Asia Pacific Continuous Glucose Monitoring market, by Country, 2015-2026 (USD Million)
  • TABLE Asia Pacific Continuous Glucose Monitoring market, by Component, 2015-2026 (USD Million)

TABLEAsia Pacific Continuous Glucose Monitoring market, by Demographic, 2015-2026 (USD Million)

  • TABLE Asia Pacific Continuous Glucose Monitoring market, by End User, 2015-2026 (USD Million)
  • TABLE Latin America Continuous Glucose Monitoring market, by Country, 2015-2026 (USD Million)
  • TABLE Latin America Continuous Glucose Monitoring market, by Component, 2015-2026 (USD Million)
  • TABLE Latin America Continuous Glucose Monitoring market, by Demographic, 2015-2026 (USD Million)
  • TABLE Latin America Continuous Glucose Monitoring market, by End User, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Continuous Glucose Monitoring market, by Country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Continuous Glucose Monitoring market, by Component, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Continuous Glucose Monitoring market, by Demographic, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Continuous Glucose Monitoring market, by End User, 2015-2026 (USD Million)

List of Figures

  • FIGURE Continuous Glucose Monitoring market segmentation
  • FIGURE Market Research Methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Component segment market share analysis, 2019 & 2026
  • FIGURE Component segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Durables (Receivers and Transmitter) market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Sensors market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Insulin Pumps market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Demographic segment market share analysis, 2019 & 2026
  • FIGURE Demographic segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Child Population market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Adult Population market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE End User segment market share analysis, 2019 & 2026
  • FIGURE End User segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Hospitals market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE ICUs market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Homecare Diagnostics market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Regional segment market share analysis, 2019 & 2026
  • FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE North America Continuous Glucose Monitoring market share and leading players, 2018
  • FIGURE Europe Continuous Glucose Monitoring market share and leading players, 2018
  • FIGURE Asia Pacific Continuous Glucose Monitoring market share and leading players, 2018
  • FIGURE Latin America Continuous Glucose Monitoring market share and leading players, 2018
  • FIGURE Middle East and Africa Continuous Glucose Monitoring market share and leading players, 2018
  • FIGURE North America Continuous Glucose Monitoring market share analysis by country, 2018
  • FIGURE U.S. Continuous Glucose Monitoring Market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Canada Continuous Glucose Monitoring Market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Europe Continuous Glucose Monitoring Market share analysis by country, 2018
  • FIGURE Germany Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spain Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Italy Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE UK Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE FranceContinuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of the Europe Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Asia Pacific Continuous Glucose Monitoring market share analysis by country, 2018
  • FIGURE India Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE China Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Japan Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE South Korea Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Singapore Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of APACContinuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin AmericaContinuous Glucose Monitoring market share analysis by country, 2018
  • FIGURE BrazilContinuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Mexico Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Argentina Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of LATAM Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Continuous Glucose Monitoring market share analysis by country, 2018
  • FIGURE Saudi Arabia Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE United Arab Emirates Continuous Glucose Monitoring market size, forecast and trend analysis, 2015 to 2026 (USD Million)